Both in Pharmaceuticals
Korsana Biosciences vs Innoviva
Over the past year KRSA returned −0.8% and INVA returned +1.7%; their daily moves had a correlation of 0.27.
KRSA −0.8% INVA +1.7%Growth of $1, one year, split-adjusted
| Metric | KRSA | INVA |
|---|---|---|
| Price | $31.66 | $21.02 |
| Market cap | $1.44B | $1.52B |
| Today | +5.04% | −0.94% |
| 1 month | +3.8% | +2.5% |
| 6 months | — | −8.6% |
| Year to date | — | +5.2% |
| 1 year | — | +17.1% |
| Revenue growth (YoY) | — | +19.3% |
| Gross margin | — | 81.3% |
| Net margin | — | −69.8% |
| P/E (TTM) | — | 4.3× |
| Price / sales | — | 3.5× |
| Net cash | — | $319.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 20.9% |
| Short % of float | 1.0% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).